Dear Friends and Colleagues,

I encourage you to actively support H.R. 5776, the bipartisan Medicare and Opioid Safe Treatment (MOST) Act, and S. 2875, the Comprehensive Opioid Management and Bundled Addiction Treatment Act of 2018 (COMBAT), which fix this gap in coverage and ensure Medicare beneficiaries’ access the treatment they need through OTPs.

I ask you to contact your Congressional representatives in support of a Medicare Part B Legislation establishing Medicare reimbursement for Opioid Treatment Programs (OTPs).

Please see the letter below from Mark Parrino, President of the American Association for the Treatment of Opioid Dependence (AATOD) and click on the links to contact your representatives.

Thank you for your support and advocacy.


Allegra Schorr


Dear Colleagues,

I am writing to ask for your support in sending letters to your Congressional representatives and Senators in support of Medicare Part B legislation, which has been introduced in both the House and the Senate.

The letter of support and Outreach Toolkit, where you can access additional information about these bills, were developed by the Advocates for Opioid Recovery (AOR). First, click HERE to contact your legislators.

This legislation, both in the House and the Senate, are the critical links to providing a Medicare benefit so that Medicare beneficiaries can seek access to treatment in opioid treatment programs. It is remarkable that after 60 years of the use of medications in OTPs, that we are finally are at the brink of getting access to such a Medicare benefit for our patients.

I am asking all treatment provider representatives and patient advocates and other such interested parties, to use this link so that you can easily get these letters out to your Congressional representatives.

Please let me know if you have any questions. This is a critically important piece of legislation both in the House and the Senate that will move this initiative forward so that such Medicare beneficiaries will finally get access to a Medicare benefit.

Thank you for doing this on behalf of our patients and our field.

With best regards,

Mark W. Parrino, M.P.A.
American Association for the Treatment of Opioid Dependence (AATOD)
225 Varick Street, Suite 402
New York, NY 10014
Ph: 212.566.5555, x200